{
    "Trade/Device Name(s)": [
        "Hemoglobin Capillary Collection System",
        "HCCS"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K090737",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070452",
        "K031043"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JKA"
    ],
    "Summary Letter Date": "March 19, 2009",
    "Summary Letter Received Date": "March 20, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated Hemoglobin Assay",
        "Blood specimen collection device"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Capillary blood",
        "Venous blood"
    ],
    "Specimen Container(s)": [
        "Plastic capillary",
        "EDTA vacuum collection tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VARIANT II Hemoglobin Testing System",
        "D-10 Hemoglobin Testing System"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-exchange high-performance liquid chromatography (HPLC)"
    ],
    "Methodologies": [
        "Sample collection and dilution for HPLC-based hemoglobin A1c analysis"
    ],
    "Submission Type(s)": [
        "Specimen collection device",
        "Reagent",
        "Sample preparation"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Hemoglobin Capillary Collection System for preparing whole blood samples for HPLC-based hemoglobin A1c measurement",
    "Indications for Use Summary": "Collection of human whole blood for percent determination of hemoglobin A1c using Bio-Rad HPLC methods, aiding in monitoring long-term glucose control in individuals with diabetes mellitus",
    "fda_folder": "Clinical Chemistry"
}